Epidemiological study and analysis on population for detecting and managing COVID-19

WHAT WE DO

RAPID TEST COVID-19

We make available for the entire population a specific analysis for the recognition of the positive patient of COVID-19 using a rapid blood test

SURVEY COVID-19

Together with the stakeholders we make a pre-triage collecting anamnestic datas to evaluate possible correlations between infections and previous or ongoing pathologies

AD-HOC SOLUTION

We prepare the best solution to manage and convey patients who developed an important immune response

emergency management

Full path from Potential Patient to Healthy Patient

APPLICATION AREAS

HEALTH CENTER

Solution that facilitates emergency management COVID-19 for monitoring the entire symptomatic patient path, in order to create effective procedures

CITIZEN/P.A.

Solution that facilitates emergency management COVID-19 on different population clusters, to define appropriate strategies for containment

ENTERPRISE

Solution that facilitates the management of the COVID-19 emergency in the working areas, with protocols of management of the symptomatic subjects and of the occupational reintegration

HOW WE DO IT

IDENTIFICATION OF GEOGRAPHICAL AREAS

Together with the stakeholders we make a pre-triage to give a better response to specific needs

IDENTIFICATION OF A CLUSTER BENCHMARK

We select the best places to perform the rapid test, such as care homes, clinics, hospitals, companies’ nurses’ stations and dispensaries, to be able to develop a service task force prevention suite COVID-19

FINE TUNED DEDICATED TEAM

We select among our team the professionals with the most suitable skills and we supply a continuous training to achieve common objectives

ROADMAP PLANNING

We share a roadmap identifying responsibilities, scheduling screening events and the various tasks to perform before, after and during the activity

IDENTIFICATION OF GEOGRAPHICAL AREAS

Together with the stakeholders we make a pre-triage to give a better response to specific needs

IDENTIFICATION OF A CLUSTER BENCHMARK

We select the best places to perform the rapid test, such as care homes, clinics, hospitals, companies’ nurses’ stations and dispensaries, to be able to develop a service task force prevention suite COVID-19

FINE TUNED DEDICATED TEAM

We select among our team the professionals with the most suitable skills and we supply a continuous training to achieve common objectives

ROADMAP PLANNING

We share a roadmap identifying responsibilities, scheduling screening events and the various tasks to perform before, after and during the activity

We work together – united against COVID-19

TEST’S PRINCIPLE

The COVID-19 IgG/IgM rapid test is a rapid immunochromatographic lateral flow test for the qualitative detection of the IgG and IgM antibodies against COVID-19 in blood samples, serum samples and human plasma

RAPID TEST COVID-19

This test is composed by two elements: the IgG component and the IgM component

1

During the test the blood sample react with COVID-19 coated particles in the box

2

The mixture migrates along the test’s membrane for capillary action and, if the blood sample contains IgG antibodies, it reacts with the anti-human IgG in the area of the line of IgG test. A colored line always appears in the area of the line of control (C). In case the blood sample contains IgG antibodies against COVID-19, a colored line appears in the area of the line of IgG test

3

Likewise, the anti-human IgM are placed in the area of the line of IgM test with whom the complex specific conjugate react if the blood sample contain IgM antibodies against COVID-19. A colored line appears in the area of the control line (C). As a result a colored line appear in the area of the test line IgM

4

In case the blood sample contain IgG antibodies and IgM antibodies against COVID-19, three colored lines appear. One colored line always appears in the area of the control line (C) and two lines are displayed in the area of the lines IgG and IgM

1

During the test the blood sample react with COVID-19 coated particles in the box

2

The mixture migrates along the test’s membrane for capillary action and, if the blood sample contains IgG antibodies, it reacts with the anti-human IgG in the area of the line of IgG test. A colored line always appears in the area of the line of control (C). In case the blood sample contains IgG antibodies against COVID-19, a colored line appears in the area of the line of IgG test

3

Likewise, the anti-human IgM are placed in the area of the line of IgM test with whom the complex specific conjugate react if the blood sample contain IgM antibodies against COVID-19. A colored line appears in the area of the control line (C). As a result a colored line appear in the area of the test line IgM

4

In case the blood sample contain IgG antibodies and IgM antibodies against COVID-19, three colored lines appear. One colored line always appears in the area of the control line (C) and two lines are displayed in the area of the lines IgG and IgM

TRAINING

Training platform and app for modular learning and course management made possible through surveys, quiz and videos. The platform is able to communicate with external services through standard protocols

 

2.0 COMMUNICATION

Platform with video materials for information and training about COVID-19 rapid test
We track the immune system response through the creation of a complete path following a specific protocol

PLATFORM B.I.

Interactive real-time dashboard to check reports regarding screening

DASHBOARD STATS QUANTITATIVE

We make available quantitative stats of carried out activities

DASHBOARD STATS QUALITATIVE

We make available qualitative stats of carried out activities

DASHBOARD STATS QUANTITATIVE

We make available quantitative stats of carried out activities

DASHBOARD STATS QUALITATIVE

We make available qualitative stats of carried out activities

We develop together effective strategies against COVID-19

All the dedicated activities allow to monitor datas in a simple and integrated way to get to know better the infection evolution in terms of clinical and instrumental parameters and secure national population

OUR SOLUTIONS

HEALTH CENTER

Solution that facilitates emergency management COVID-19 for monitoring the entire symptomatic patient path, in order to create effective procedures

CITIZEN/P.A.

Solution that facilitates emergency management COVID-19 on different population clusters, to define appropriate strategies for containment

ENTERPRISE

Solution that facilitates the management of the COVID-19 emergency in the working areas, with protocols of management of the symptomatic subjects and of the occupational reintegration

HEALTH CENTER

Solution that facilitates emergency management COVID-19 for monitoring the entire symptomatic patient path, in order to create effective procedures

CITIZEN/P.A.

Solution that facilitates emergency management COVID-19 on different population clusters, to define appropriate strategies for containment

ENTERPRISE

Solution that facilitates the management of the COVID-19 emergency in the working areas, with protocols of management of the symptomatic subjects and of the occupational reintegration